Objectives: Cardiac remodeling due to myocardial infarction (MI) includes myocyte hypertrophy, collagen deposition, a rise in DNA synthesis, and normalization of initially diminished maximal coronary bloodflow. Previously, we demonstrated that early captopril treatment can prevent the rise in total DNA synthesis, collagen deposition and hypertrophy. In the present experiments, we investigated the effects of captopril or perindoprilat treatment on cardiac endothelial cell proliferation and maximal coronary flow. Methods: MI was induced by ligation of the left coronary artery in Wistar rats. Sham-operated and infarcted rats were treated with captopril (12 mg / kg.d s.c.) from either day 0-21 (early) or day 21-35 (late) after surgery. In isolated retrogradely perfused rat hearts, maximal coronary flow was determined following maximal dilatation with nitroprusside and adenosine (1 mM each). In separate groups, sections of hearts of sham-operated and MI rats treated with BrdU (day 7-14) and either captopril or perindoprilat (1 mg / kg.d s.c.; day 0-14) were double stained with a monoclonal anti-BrdU antibody and the lectin GSI. The total fraction of DNA synthesizing cells and its proportion of endothelial cells was determined. Results: Maximal coronary flow was completely normalized in MI hearts within three weeks after surgery. Early captopril, but not late captopril, inhibited the normalization of maximal coronary flow in MI hearts (Early: sham, 27.461.0; MI, 21.261.4 ml / min; P,0.05; mean6SEM) without affecting the hypertrophic response. The total fraction of DNA synthesizing cells was significantly increased in MI hearts (sham: 7.661.9; MI: 14.962.2%). The proportion of endothelial cells, however, was comparable in sham-operated and infarcted hearts (sham: 3063; MI: 3363%). Both early captopril and perindoprilat treatment inhibited total DNA synthesis in MI hearts. Only in captopril pre-treated hearts, this inhibition was associated with a disproportionate inhibition of the endothelial cell proliferation (10.362.0%). Conclusion: Early captopril treatment inhibits endothelial cell proliferation and coronary vessel growth following MI, which seems to be partly due to inhibition of the renin angiotensin system.
Introduction
. These changes in the non-infarcted part are associated with an early increase in DNA synthesis [3] , which is Induction of myocardial infarction (MI) induces repredominantly localized in fibroblasts and endothelial cells modeling of both the infarcted and the non-infarcted [5] . Furthermore, total maximal coronary flow normalizes regions of the heart [1]. Structural remodeling in the within 5 weeks after MI due to a combination of recruitinfarcted part results predominantly in dilatation, scarring, ment of pre-existing coronary vessels and growth of new and thinning of the infarcted tissue, whereas remodeling of vessels [6] . the non-infarcted part of the ventricles includes hyper-
The cardiac renin-angiotensin system (RAS) plays an trophy of the myocytes, and an increase in collagen content important role in the remodeling processes of the heart. With respect to angiotensin converting enzyme (ACE), both increased activity and mRNA expression were ob-2.2. Myocardial infarction surgery served in rat hearts with pressure overload-induced hypertrophy [7] , in the right ventricle and the septum of Myocardial infarction (MI) was induced by coronary infarcted rat hearts [8] , and in the left ventricle of failing artery ligation under pentobarbital anesthesia (60 mg / kg human hearts [9] . Similarly, we previously observed an i.p.) [14, 15] . Intraoperatively, the animals were respirated increase in mRNA expression in the infarcted rat heart with room air (60 strokes / min, tidal volume 3 ml) after the [10] .
trachea was intubated. After thoracotomy in the fourth left Late captopril treatment (week 3-5 following MI) intercostal space, the heart was exteriorized and a 6-0 silk significantly improved cardiac function [11, 12] , and insuture was passed under the left anterior descending creased the 1 year survival rate of MI rats [13] . It had no coronary artery (LAD) near the origin of the pulmonary effect on cardiac collagen deposition and DNA synthesis artery. In sham-operated animals the suture was looped [3] . In contrast, early captopril treatment (week 0-3 through the myocardium next to the LAD. After the heart following MI) worsened cardiac function in MI rats [11] .
was returned to its normal position, the suture was tied. This negative effect on cardiac function was associated
The ribs were pulled together with 3-0 silk, and the skin with inhibition of the rise in total DNA synthesis and was sutured. Animals were allowed to recover for 14 days collagen deposition [3] . It is, however, not known whether in histological experiments and for 21 or 35 days in captopril treatment also affects the previously observed perfusion experiments. normalization of maximal coronary flow, which is due to a combination of recruitment of pre-existing coronary ves-2.3. Perfusion experiments sels and growth of new vessels [6] . To investigate the effect of captopril treatment on coronary vessel growth in 2.3.1. Treatment infarcted hearts, both endothelial cell proliferation, as an Osmotic mimipumps were implanted subcutaneously in index for vessel growth, and maximal coronary flow were the neck under ether anesthesia and rats were infused with quantified in sham-operated and infarcted hearts following captopril (12 mg / kg.d s.c., Alzet 2001; Alza, Palo Alto, early captopril treatment. Endothelial cell proliferation was USA). Early captopril treatment (day 0-21) started immemeasured at day 14, because DNA synthesis is maximal diately after sham or MI surgery and was continued for 3 between day 7 and 14 and returns to baseline within 3 weeks. Late captopril treatment (day 21-35) started 3 weeks [3] . Because the outcome of the proliferative weeks after sham or MI surgery and captopril was infused response (i.e. vessel growth) should be expected to be for 2 weeks. Osmotic minipumps were replaced every complete at 3 weeks after MI, which agrees with our week under ether anesthesia. observations [6] , the effect of captopril treatment on this normalization was investigated at day 21. In addition, maximal coronary flow was investigated in sham-operated 2.3.2. Isolated heart perfusion and infarcted hearts following late captopril treatment (day Isolated hearts were perfused as described previously 21-35). To evaluate the ACE specificity of the captopril [6, 16] . Under pentobarbital anesthesia (60 mg / kg i.p.), effects, also total proliferation and endothelial cell proliferhearts of MI and sham-operated animals (day 21 or 35) ation were investigated following early perindoprilat treatwere rapidly excised and immediately immersed in icement.
chilled perfusion medium (see below). After removal of lung and fat tissue, hearts were connected to the aortic cannula of the perfusion system and retrograde perfusion (Langendorff perfusion model) was started at a perfusion pressure of 60 mmHg.
Methods
The hearts were perfused with a modified Krebs-Henseleit solution (mM: NaCl, 130; KCl, 5. 
. Measurement of infarct size
2002; a generous gift from dr. E. Scalbert, Servier, Paris, To measure infarct size, the hearts were cut into France) from day 0 to 14. In pilot experiments, the doses transverse slices of 1-2 mm, resulting in 4 slices. In used of perindoprilat and captopril resulted in a comparprevious experiments, we investigated the correlation able shift of the angiotensin I dose-pressure curve (data between the mean infarct size and the infarct size at four not shown). different levels (level 1 is basal level; level 4 is apical level). As demonstrated in Fig. 1 , there was a very good 2.4.3. BrdU infusion correlation between the mean infarct size and the infarct Osmotic minipumps were implanted subcutaneously in size at level 2 (mid-ventricular slice). Therefore, the midthe neck under ether anesthesia, and sham-operated and ventricular slice was fixed with formalin and embedded in infarcted rats were infused with BrdU (0.8 mg / kg.d s.c., paraffin, whereafter transverse sections (4 mm) were Alzet 2001) from day 7 to 14. stained according to the modified AZAN technique [3] . Infarct size was determined by computerized morphometry 2.4.4. Double staining of heart sections At day 14, the rats were anesthetized with ether. The hearts of BrdU treated rats were arrested in diastole by injecting 2 ml 0.1 M CdCl into the inferior caval vein and 2 perfused via a catheter in the abdominal aorta with phosphate buffered saline (PBS, pH 7.4), containing 0.5 mg / ml nitroprusside (Hoffmann-La Roche, Mijdrecht, the Netherlands) for 5-10 min at a pressure of approximately 100 mmHg. Thereafter, the hearts were perfusion-fixed for 10 min with 10% phosphate buffered formalin (1:1 diluted in PBS), containing 0.5 mg / ml nitroprusside. The hearts were removed and stored in 10% phosphate buffered formalin for 24 h at room temperature. Subsequently, the hearts were cut into transverse slices of 4 mm, processed and embedded in paraffin.
To discriminate between DNA synthesizing endothelial cells and non-endothelial cells in the non-infarcted part of the myocardium, transverse sections (4 mm) were double stained with the lectin Griffonia Simplicifolia I (GSI; Sigma, St. Louis, USA) and a monoclonal anti-BrdU antibody (Eurodiagnostics, Apeldoorn, the Netherlands), as previously described [5] . Therefore, the sections were mark) for 30 min at room temperature and development cells per heart were counted, whereas for the double with Fast Blue BB' (Sigma, St. Louis, USA). The staining staining at least 500 BrdU positive nuclei were counted. of BrdU incorporation with a murine monoclonal anti-
The percentage of BrdU positive nuclei was calculated BrdU antibody was performed as described previously [3] .
from the number of BrdU positive cells and the total A representative picture of the double staining is presented number of cells. The percentage of BrdU positive endoin Fig. 2 .
thelial cells was calculated from the number of BrdU To quantify the total number of DNA synthesizing cells, positive endothelial cells and the total number of BrdU parallel sections were stained with the monoclonal antipositive cells. BrdU antibody only (single staining).
Infarct size was determined in the mid-ventricular slice, as described above.
Measurements
Total DNA synthesizing cells and the amount of DNA synthesizing endothelial cells were determined in hearts of 2.5. Data analysis untreated and treated sham-operated and infarcted rats. The origin of all samples was blinded to the investigators. Cell
Only hearts with infarct sizes .21% were used in the numbers were determined microscopically with an MI groups, since smaller infarcts do not have detectable eyepiece grid (4003 magnification), as described previoushemodynamic consequences in vivo [11] . ly [3] . All measurements were performed by two exData from all experiments were compared by one-way perienced investigators. Intra-and inter-observer variations analysis of variance followed by a post-hoc test. For were less than 10%.
comparison of groups to untreated sham animals, we used DNA synthesizing endothelial cells in the subendocarDunnett's test, defining untreated sham rats as controls. dial region of the left ventricle (septum and papillary
For all other comparisons, we employed a Bonferroni muscle) were identified based on the co-localisation of procedure [17] . Data were expressed as mean6SEM. both BrdU positive nuclei and GSI stained microvascular Differences were regarded to be statistically significant at a profiles. For the single BrdU staining a total of 700-1300 value of P,0.05. 
Results

Perfusion experiments
Induction of MI resulted in an increase in heart weight, although only significantly at day 35 (Table 1) . Neither early nor late captopril treatment affected body and heart weight. Infarct sizes were comparable in the groups.
Basal coronary flow was comparable in sham-operated and infarcted hearts at days 21 and 35, and was not coronary flow in untreated sham-operated and infarcted hearts at days 21 and 35 following surgery (Fig. 3) . Both in sham-operated and infarcted hearts, maximal coronary flow was unaffected by late captopril treatment (day 21-35). In contrast, early captopril treatment (day 0-21) inhibited the normalization of maximal coronary flow in infarcted hearts. In sham-operated rats, captopril treatment had no significant effect on maximal coronary flow.
Structural experiments
The total labeling fraction of DNA synthesizing cells in sham-operated hearts was 7.661.9% (Fig. 4A) . Of these DNA synthesized in sham-operated hearts (32.061.2%), Early captopril treatment (day 0-14) inhibited total but was associated with a disproportionate inhibition of DNA synthesis both in sham-operated (4.060.5%) and MI DNA synthesis in endothelial cells in MI hearts hearts (7.861.5%; Fig. 4A ). As shown in Fig. 4B , the (10.362.0%). inhibition of DNA synthesis by early captopril treatment Early perindoprilat treatment (day 0-14) inhibited total had no effect on the proportion of endothelial cells that DNA synthesis in MI hearts (Fig. 4A) . In contrast to captopril, the inhibition of DNA synthesis by early perinThe reason for this inconsistency is not clear, but does not doprilat tretament had no effect on the proportion of seem to depend on doses used and / or duration of therapy. endothelial cells that DNA synthesized in MI hearts Due to unaltered heart weights in captopril pre-treated rats, (32.761.3%; Fig. 4B) .
the observed decrease in maximal coronary is not caused by a diminshed heart weight in the present experiment. Metsarinne and colleagues [27] demonstrated an inhibitory effect of angiotensin II on rat coronary endothelial 4. Discussion cell proliferation in vitro. In the presence of the AT -2 receptor antagonist PD123177, however, angiotensin II In previous experiments, we demonstrated that followinduced proliferation of these cells, whereas the addition of ing MI remodeling processes in the non-infarcted part of the AT -receptor antagonist losartan reversed this effect 1 the heart are characterized by an increase in collagen [28] . In contrast to these observations in cell culture, we content, and an early increase in DNA synthesis, which is recently observed a partial inhibition of DNA synthesis in mainly confined to fibroblasts and endothelial cells (reinfarcted rat hearts following early treatment with the viewed in ref. [1] ). Recently, we observed a complete AT -antagonist PD123319 [29] .
2 normalization of maximal coronary flow within 5 weeks Thus far, the influence of the RAS on coronary vascuafter MI due to a combination of recruitment of prelarization and coronary flow has predominantly been existing vessels and growth of new coronary vessels in the investigated in hypertensive patients and hypertensive borderzone between infarcted and surviving myocardium animal models. In hypertension, the increase in vasculari- [6] . The increase in collagen content and the early rise in zation is mainly secondary to hypertrophic growth of the (total) DNA synthesis following MI could be prevented by myocytes and to a lesser extent to normal tissue growth. early (0-3 weeks) captopril treatment [3] . In the present
The increase in vascular density or coronary flow, howexperiments, we investigated the effect of chronic captopril ever, is not proportional to the hypertrophic growth treatment on endothelial cell DNA synthesis and its response [30] [31] [32] [33] , although the increase in coronary flow possible functional consequences on maximal coronary seems to depend on the duration of hypertension [34, 35] . flow.
Long-term treatment with the ACE inhibitor enalapril Maximal coronary flow was comparable in hearts of decreased minimal coronary resistance and increased maxiuntreated sham-operated and infarcted rats both at days 21 mal coronary flow and flow reserve in hypertensive and 35, which confirms our previous findings [6] . Late patients with angina pectoris [36] . In hypertension induced captopril treatment did not affect maximal coronary flow.
by aortic-banding, 4-weeks of captopril treatment deIn contrast, early captopril treatment significantly decreased minimal coronary resistance, and thus increased creased maximal coronary flow in infarcted hearts but not maximal coronary flow [23] . Long-term ramipril treatment in sham-operated hearts. Moreover, total DNA synthesis (20 week; treatment started in utero) of spontaneously was inhibited in sham-operated and MI hearts following hypertensive rats (SHR) increased myocardial capillary early captopril treatment, which was associated with a length density, independent of blood pressure reduction or disproportionate inhibition of endothelial cell proliferation.
inhibition of development of hypertrophy [37] . In the The inhibition of total DNA synthesis in MI hearts cremaster muscle, however, an inhibition of vascular following early perindoprilat treatment, however, was growth has been observed following long-term captopril associated with a proportional inhibition of endothelial cell treatment in one-kidney, one clip hypertensive rats [38] . proliferation. These experiments clearly indicate that early Thus, in hypertensive patients and in most hypertensive captopril treatment inhibits endothelial cell proliferation animals, long-term ACE inhibition enhances maximal and coronary vessel growth following MI, which seems to coronary flow, due to a more pronounced outgrowth of the be partly due to inhibition of the RAS.
coronary vascularization. The observations in hypertension In the present experiments, the hypertrophic response are in contrast to observations in non-hypertensive models. following induction of MI was not inhibited by captopril.
Angiogenic responses to angiotensin II have been deThis is in contrast with the general believe that captopril scribed in chick chorioallantoic membrane [39] , in dog prevents cardiac hypertrophy. In literature, however, the kidney [40] , and rabbit cornea [41] . Furthermore, Munzenobservations concerning a regression of cardiac hypermaier and Greene [42] observed an increase in vessel trophy following captopril treatment in infarcted rats are density in rat cremaster muscle following a subpressor not consistent. Several studies demonstrated no regression dose of angiotensin II. In a rat model for chronic peripheral of cardiac hypertrophy following late captopril treatment ischemia, we previously observed an abolishment of the [11, 18, 19] , whereas others showed a diminished heart increase in capillarization in soleus muscles by ACE weight in rats with large infarct sizes [12, 20] . Also inhibitors [43] . The observations in this latter model of following early captopril treatment, the observations are ischemia are consistent with the observations in the present not consistent. Both a regression [3, 11, 21, 22] and no chronic ischemia model. The discrepancy between hyregression of cardiac weight [23] [24] [25] [26] have been observed. pertensive models and severely ischemic models suggests that the role of the RAS in vessel growth may depend on following MI, its effect on the coronary system, and the the pathophysiological condition.
effect of ACE inhibition thereupon. For technical reasons, The inhibition of endothelial cell proliferation and we chose the septum and papillary muscles for the coronary vessel growth following early ACE inhibition quantitation of BrdU / lectin staining. In contrast, maximal may depend on the blood pressure lowering effect of the coronary flow is obviously an overall measure. There may ACE inhibitor. Late captopril treatment, however, did not be regionally different adaptive mechanisms in the healthy prevent the normalization in maximal coronary flow, ventricle versus the borderzone. Our functional methods do despite a comparable decrease in blood pressure [11] .
not allow to differentiate between the effects on coronary Furthermore, chronic treatment with the vasodilator hyvessels in septum, borderzone and infarcted area. Howdralazine did not lower total DNA synthesis in MI hearts ever, we previously demonstrated a very low coronary flow [3], suggesting a lack of involvement of blood pressure in the infarcted area [6] . Therefore, it is not likely that reduction in the present observations. The contribution of blood vessels in the infarct zone contribute to the observed elevated bradykinin levels due to inhibition of its degraeffects in a significant manner. On the other hand, the dation can not be ruled out. Thus far, however, only a borderzone may be an interesting area, because coronary stimulatory rather than an inhibitory effect of bradykinin blood flow following MI was enhanced in this area [6] . We on endothelial cell proliferation in vitro [44] and on tried to quantify total DNA synthesis and endothelial cell myocardial capillary growth in hypertensive rats [45] has proliferation in the borderzone of MI hearts, but no been described. reproducible data could be obtained. Nonetheless, we A more likely explanation for the present observations is demonstrated both a diminished endothelial cell proliferthe prevention of (local) angiotensin II formation by ation in the healthy part of the MI heart and a diminished inhibition of ACE. Munzenmaier and Greene observed an maximal coronary flow. This suggests that the alterations increase in vessel density in rat cremaster muscle followobserved in the healthy part of the infarcted heart substaning a subpressor dose of angiotensin II, which was tially contribute to the maximal coronary blood flow. enhanced following co-infusion of the AT -antagonist
In conclusion, early captopril treatment inhibits endo- PD123177 resulted in a stimulation of proliferation. Thus, beneficial, inhibition of cardiac ACE in the early phase in vivo the balance may be in favour of (AT -mediated) after myocardial infarction may inhibit the functional 1 proliferation, whereas in vitro, inhibition (AT -mediated) adaptation of the infarcted heart. Besides inhibition of 2 may be favoured. In infarcted hearts, we recently observed cardiac ACE, captopril may also influence other ana partial inhibition of DNA synthesis following early giogenic factors involved in the coronary vascular retreatment with the AT -antagonist PD123319 [29] . modeling following MI. 2 In contrast to early treatment with perindoprilat or with the AT -antagonist PD123319 [29] , captopril treatment 2 resulted in a disproportionate inhibition of proliferating Acknowledgements endothelial cells in hearts of infarcted rats. This suggests that in addition to the effect on the RAS, captopril may This work was supported by grant 902-18-291 from the influence other angiogenic factors involved in coronary Dutch Heart Foundation and NWO (the Netherlands). We vascular remodeling following MI, like VEGF, FGF, TGFthank Elsbeth A. Raes and Anique J.M.H. Janssen for a, IGF-I, and PDGF [46] . expert technical assistance. Previously, we observed a worsening of cardiac function in infarcted rats following early captopril treatment [11] . The inhibition of e.g. cardiac collagen deposition in the References early phase following MI was assumed to be responsible for the deleterious effect of early captopril treatment [1].
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